Can GMO Mosquitoes Save You From Dengue?

To combat dengue fever, a biotech firm unleashes genetically engineered bloodsuckers. What could possibly go wrong?

Illustration: David Goldin

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


In August 2009, a 34-year-old woman from Rochester, New York, went to her doctor complaining of flulike symptoms. The doc ordered some blood tests, which came back positive for dengue fever, a mosquito-borne virus that can cause serious illness and sometimes death­—a baffling diagnosis, since the woman hadn’t recently traveled anyplace where dengue is endemic. She had, however, been to Key West, where, in the months that followed, more tourists and residents were diagnosed. Thus began Florida’s first significant dengue outbreak since 1934. Some scientists postulated that climate change has made the region more hospitable to Aedes aegypti, the primary species known to spread the virus.

The agency in charge of mosquito control for the Keys responded by blanketing the city with pesticides targeting both larvae and adult mosquitoes. Even so, the outbreak lasted for 15 months and sickened 93 people. While there hasn’t been a new case since November 2010, local leaders aren’t eager to relive the nightmare. And now they figure they won’t have to, thanks to a recent high-tech innovation: self-destructing mosquitoes.

These specialized skeeters, developed by the British company Oxitec, are genetically engineered to need the antibiotic tetracycline—common in the lab but scant in the wild—in order to survive past the larval stage. The altered males mate with wild females and presto: Lacking tetracycline to feed on, their offspring die before they’re old enough to bite.

So far, Oxitec has teamed up with local officials and released its critters in Brazil, Malaysia, and the Cayman Islands—where the company claims an 80 percent decline in the Aedes aegypti population over three months. Mosquito control wonks everywhere were impressed. Oxitec’s method can cost less than spraying, never mind the nasty chemicals: Key West would pay $200,000 to $400,000 a year for eggs versus $800,000 for the pesticides. Oxitec CEO Hadyn Parry, a former employee of the agribusiness giant Syngenta, sees his company’s product as a humanitarian triumph. “We want to make this as widely available as we can,” he says.

This February the company secured an investment of $13 million to expand its technology. “The success of our funding round,” proclaims Oxitec’s press release, “underlines the confidence investors from around the world have in our approach and its potential.” In a similar but separate project, scientists from the University of California-Irvine are testing out their own Aedes aegypti mutants, which are engineered to produce flightless offspring.

But not everyone is convinced that this sort of approach is a silver bullet. “This technology hasn’t been properly tested, nor is it clear that it’s going to work,” says Eric Hoffman, who tracks genetic engineering issues for the environmental group Friends of the Earth. “The public isn’t being told the whole truth.”

For starters, Hoffman says, no one quite knows what will happen to an ecosystem suddenly devoid of Aedes aegypti. Suppose a worse mosquito species takes over? Of particular concern is the so-called Asian tiger. One of the most invasive species in the world—and a potential dengue carrier—it breeds extremely rapidly and may require great quantities of pesticide to control. (Oxitec says it has an answer for that: Mutant Asian tigers are in the works, which raises the weird specter of an endless succession of engineered bloodsuckers.)

Then there are the offspring that don’t self-destruct. Oxitec admits that a small percentage of its altered mosquitoes, including biting females, can survive in the lab without tetracycline. Introducing any new engineered species into the wild, Hoffman says, brings up the possibility that we may be allergic to it.

CEO Parry says independent studies commissioned by his company suggest that allergens won’t be an issue. But maybe more to the point, he concedes that the company doesn’t know whether its method can reduce dengue over the long term. To date, the most important weapon against the disease has been public education. “When people are taught to police their own homes for potential breeding areas”—cisterns, kiddie pools, even old soda cans—”incidence of dengue decreases,” says Phil Lounibos, a medical entomologist at the University of Florida.

It’s troubling, then, that Oxitec doesn’t have a great track record when it comes to educating the locals about its bugs. In the Caymans, many people didn’t realize the firm’s mosquitoes had been released until after the fact. And it wasn’t until this March, after media reports had Key Westers riled up over the prospect of mutant skeeters, that mosquito control officials finally scheduled a public meeting with Oxitec in the house to answer questions. The same officials say they’re awaiting federal approval before actually unleashing any mosquitoes. The FDA won’t say how long that might take—only that it will review the scientific issues “rigorously.”

That’s one case of regulatory heel-dragging I can get behind.

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate